SI0728001T1 - Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections - Google Patents

Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections

Info

Publication number
SI0728001T1
SI0728001T1 SI9430411T SI9430411T SI0728001T1 SI 0728001 T1 SI0728001 T1 SI 0728001T1 SI 9430411 T SI9430411 T SI 9430411T SI 9430411 T SI9430411 T SI 9430411T SI 0728001 T1 SI0728001 T1 SI 0728001T1
Authority
SI
Slovenia
Prior art keywords
treatment
prophylaxis
infections
herpes virus
purine derivatives
Prior art date
Application number
SI9430411T
Other languages
English (en)
Slovenian (sl)
Inventor
HODGE Richard Anthony SmithKline Beecham VERE
Malcolm Richard SmithKline Beecham Pharm. BOYD
Original Assignee
Novartis International Pharmaceutical Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis International Pharmaceutical Ltd. filed Critical Novartis International Pharmaceutical Ltd.
Publication of SI0728001T1 publication Critical patent/SI0728001T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI9430411T 1993-11-12 1994-11-08 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections SI0728001T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939323403A GB9323403D0 (en) 1993-11-12 1993-11-12 Pharmaceuticals
PCT/EP1994/003697 WO1995013073A1 (en) 1993-11-12 1994-11-08 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
EP95900126A EP0728001B1 (en) 1993-11-12 1994-11-08 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections

Publications (1)

Publication Number Publication Date
SI0728001T1 true SI0728001T1 (en) 2002-04-30

Family

ID=10745091

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9430411T SI0728001T1 (en) 1993-11-12 1994-11-08 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections

Country Status (18)

Country Link
US (1) US6057327A (da)
EP (1) EP0728001B1 (da)
JP (1) JP4453880B2 (da)
KR (1) KR100341737B1 (da)
CN (1) CN1074925C (da)
AT (1) ATE210985T1 (da)
AU (1) AU690159B2 (da)
CA (1) CA2176376C (da)
CY (1) CY2338B1 (da)
DE (1) DE69429538T2 (da)
DK (1) DK0728001T3 (da)
ES (1) ES2169116T3 (da)
GB (1) GB9323403D0 (da)
HK (1) HK1012233A1 (da)
PT (1) PT728001E (da)
SI (1) SI0728001T1 (da)
WO (1) WO1995013073A1 (da)
ZA (1) ZA948907B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009067630A1 (en) * 2007-11-21 2009-05-28 Exley Ray W 2-amino purine derivatives and their use as anti-herpetic agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0141927B1 (en) * 1983-08-18 1991-10-30 Beecham Group Plc Antiviral guanine derivatives
EP0182024B1 (en) * 1984-09-20 1991-04-03 Beecham Group Plc Purine derivatives and their pharmaceutical use
DE3671227D1 (de) * 1985-07-27 1990-06-21 Beecham Group Plc 9-substituierte guaninmonohydrate.
AU635642B2 (en) * 1990-05-24 1993-03-25 E.R. Squibb & Sons, Inc. Fluorinated bis(hydroxymethyl) cyclobutyl purines and pyrimidines
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment

Also Published As

Publication number Publication date
CA2176376C (en) 2007-10-02
ZA948907B (en) 1995-08-17
AU690159B2 (en) 1998-04-23
CN1136276A (zh) 1996-11-20
CA2176376A1 (en) 1995-05-18
CY2338B1 (en) 2004-02-06
HK1012233A1 (en) 1999-07-30
ES2169116T3 (es) 2002-07-01
WO1995013073A1 (en) 1995-05-18
AU8106794A (en) 1995-05-29
GB9323403D0 (en) 1994-01-05
JP4453880B2 (ja) 2010-04-21
US6057327A (en) 2000-05-02
PT728001E (pt) 2002-06-28
JPH09511217A (ja) 1997-11-11
DK0728001T3 (da) 2002-04-15
DE69429538T2 (de) 2002-07-25
DE69429538D1 (de) 2002-01-31
ATE210985T1 (de) 2002-01-15
EP0728001A1 (en) 1996-08-28
CN1074925C (zh) 2001-11-21
EP0728001B1 (en) 2001-12-19
KR100341737B1 (ko) 2002-11-25

Similar Documents

Publication Publication Date Title
HK1082684A1 (en) Use of B-D-dioxolanyl nucleosides in the manufacturing pharmaceuticals
GB8904855D0 (en) Pharmaceutical treatment
HK1012234A1 (en) Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection
CY2525B1 (en) Use of penciclovir for the treatment of human herpes-virus-8
HK1012233A1 (en) Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
CA2207503A1 (en) Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia